CSR Report

Overview

The report presents Dermapharm Holding SE's 2022 CSR performance, including Group revenue of EUR 1,024.8 million. It describes responsibility for sustainability at full Board level, supported by an ESG Committee, and reports no fatal workplace accidents during the year. The report also includes environmental, EU Taxonomy and SDG Index disclosures.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2022
Publication date: 27 March 2023
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Ratings

GRI level

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services